Oncosil Medical Ltd
ASX:OSL
Oncosil Medical Ltd
ASX:OSL
Price:
0.004 AUD
-20%
Market Closed
Updated:
May 2, 2024
Oncosil Medical Ltd
Operating Income
|
Oncosil Medical Ltd
Operating Income Peer Comparison
Comparables:
ADO
PIQ
CTE
GSS
E
EZZ
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oncosil Medical Ltd
ASX:OSL
|
Operating Income
-AU$11.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-16%
|
|
|
Anteotech Ltd
ASX:ADO
|
Operating Income
-AU$15.2m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-15%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Operating Income
-AU$6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Operating Income
AU$1.7m
|
CAGR 3-Years
26%
|
CAGR 5-Years
230%
|
CAGR 10-Years
5%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Operating Income
-AU$18m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Operating Income
AU$6.4m
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncosil Medical Ltd's Operating Income?
Operating Income
-11.5m
AUD
-11.5m
AUD
Based on the financial report for Dec 31, 2023, Oncosil Medical Ltd's Operating Income amounts to -11.5m AUD.
What is Oncosil Medical Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-16%
-16%
Over the last year, the Operating Income growth was -9%. The average annual Operating Income growth rates for Oncosil Medical Ltd have been -26% over the past three years , -5% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
